![Hoe eenvoudige semantiek onze AI-citaties met 642% verhoogde [Nieuwe resultaten]](https://www.pharmamarketeer.nl/wp-content/uploads/2026/01/719-370x300.jpg)
Influenza drug baloxavir marboxil significantly sped time to relief for patients highly vulnerable to serious complications, a late-stage clinical trial has shown, Swiss drugmaker Roche said on Thursday.
Prijsonderhandelingen dure medicijnen leiden tot forse kostenverlaging
Sinds enkele jaren onderhandelt de minister voor Medische Zorg met fabrikanten van nieuwe en zeer dure geneesmiddelen. Doel is om deze waardevolle innovatieve geneesmiddelen tegen aanvaardbare kosten toegankelijk te...
Persbericht: NVFM en MOA worden kennispartners
De NVFM (Nederlandse Vereniging voor Farma Managers) en MOA Profgroep Healthcare voor insight professionals gaan nauwer samenwerken! De gezondheidszorg verandert exponentieel snel en daarmee ook het vak van...
Positief advies voor galcanezumab voor preventie migraine
Het monoklonale antilichaam galcanezumab (Emgality) heeft van de Committee for Medicinal Products for Human Use (CHMP) een positief advies gekregen voor een handelsvergunning als preventie bij migraine.
Eli Lilly’s diabetes treatment meets main goal in two late-stage studies
Eli Lilly and Co said on Tuesday its experimental diabetes treatment was shown to be as effective as the drugmaker’s Humalog medicine in two late-stage studies.
Triple T van B2B-marketing: Trust, Transparantie en Technologie
Eén van de slechte ontwikkelingen binnen het marketingvak is de verbastering en daarmee devaluering van het woord marketing. Direct marketing, online marketing, influencermarketing, digital marketing, interne marketing...
Eisai’s antiepileptic drug receives FDA approval to treat partial-onset seizures in pediatric patients
Eisai Co., Ltd. announced today that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administration for an indication expansion for Eisai’s antiepileptic drug Fycompa (perampanel) to...
Trends in marketing & tech: relevanter & beter
Volgens keynote-speakers op Content Marketing World gaan we van snackable content naar longformsmet betekenis en staan we aan de vooravond van de doorbraak van AI en AI-gerelateerde technologieën. Balans vinden tussen...
AmerisourceBergen to pay $625 million in U.S. civil fraud settlement
AmerisourceBergen Corp, one of the largest U.S. drug wholesalers, will pay $625 million to resolve civil fraud charges, including selling adulterated and unapproved drugs for cancer patients, double billing, and...
Over personal branding en het geloof in de gunfactor
Ken je dat gevoel dat je net iets heel gaafs hebt meegemaakt en dat je niet kan wachten om het je familie en vrienden te vertellen? Het liefst bel je ze meteen of nee, beter nog, je knalt het op social media. Kan de...
Antares Pharma’s testosterone drug gets FDA approval
The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc’s drug to treat low testosterone levels in men, the company said, nearly a year after rejecting the injection.
Scientists behind game-changing cancer immunotherapies win Nobel medicine prize
American James Allison and Japanese Tasuku Honjo won the 2018 Nobel Prize for Physiology or Medicine on Monday for game-changing discoveries about how to harness and manipulate the immune system to fight cancer.
U.S. FDA approves Lilly migraine drug; price same as rivals
Eli Lilly and Co on Thursday said the U.S. Food and Drug Administration approved its migraine drug Emgality, marking the third approval from a promising new class of treatments for the often debilitating headaches.
Pfizer’s lung cancer drug gets FDA approval
Pfizer Inc said on Thursday that its once-daily oral drug to treat a rare form of lung cancer received approval from the U.S. Food and Drug Administration.
Marketing tussen feit en visie
Als marketeer ken je ze vast wel van de congressen die je met enige regelmatig bezoekt: slides met visionaire quotes die je vertellen hoe wij ons werk anders zouden moeten doen. Blauwe oceanen, de ‘crazy people’ van...
Sandoz’s Symjepi receives US FDA approval for allergic reactions in children
Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, announced that the US Food and Drug Administration has approved Symjepi (epinephrine) 0.15 mg injection for the emergency treatment of allergic...
FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex
The U.S. Food and Drug Administration today approved a new drug, Arikayce, for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex in a limited population of patients with the...
FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma
The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who...
